This bill amends existing laws regarding the management of anaphylaxis medications in schools, specifically RCW 28A.210.383 and RCW 28A.210.380. It allows school districts and private schools to maintain a supply of epinephrine, including autoinjectors, for emergency use based on student enrollment. Licensed health professionals can prescribe these medications in the name of the school, and the bill clarifies that there are no changes to current practices for students with existing prescriptions. Additionally, it establishes protocols for school nurses and trained personnel to administer epinephrine during an anaphylactic reaction, whether or not a student has a personal prescription on file. The bill also includes provisions for reimbursement of epinephrine costs and outlines liability protections for school employees administering the medication.

Furthermore, the bill mandates the development of anaphylactic policy guidelines by the office of the superintendent of public instruction in consultation with the department of health. These guidelines will include procedures for treatment plans, training for school personnel, communication strategies regarding students with allergies, and risk reduction strategies. The bill emphasizes the importance of training and certification for staff involved in managing anaphylaxis, ensuring that schools are better equipped to handle such medical emergencies.

Statutes affected:
Original Bill: 28A.210.383, 28A.210.380
Substitute Bill: 28A.210.383, 28A.210.380